Tyrosine kinase inhibitors

Aus coViki
Wechseln zu: Navigation, Suche

ok some other kinases included...

PAK-1 target

  • GET ä. PAK1-blockers: Potential Therapeutics against COVID-19? Extract
  • GET ä. Chemical evolution for taming the ?pathogenic kinase? PAK1 Extract


  • GET ä. Imatinib might constitute a treatment option for lung involvement in COVID-19 Extract
  • GET 2020. Imatinib for COVID-19: A case report. Extract

BTK Bruton Tyrosine Kinase ibrutiib

  • GET 2020. The BTK inhibitor ibrutinib may protect against pulmonary injury in COVID-19-infected patients Extract
  • GET 2020. Inhibition of Bruton tyrosine kinase in patients with severe COVID-19. Extract
  • GET 2020. Protective role of Bruton tyrosine kinase inhibitors in patients with chronic lymphocytic leukaemia and COVID-19. Extract
GET 2020. A rationale for blocking thromboinflammation in COVID-19 with Btk inhibitors. Extract

akt PKB

  • GET 2020. Is targeting Akt a viable option to treat advanced-stage COVID-19 patients? Extract

Abelson tyrosine kinase

  • GET 2020. Lessons learned from SARS-CoV and MERS-CoV: FDA-approved Abelson tyrosine-protein kinase 2 inhibitors may help us combat SARS-CoV-2. Extract
  • GET 2020. SARS-CoV-2 (COVID-19) and Chronic Myeloid Leukemia (CML): a Case Report and Review of ABL Kinase Involvement in Viral Infection. Extract

p38 mapk

  • GET 2020. p38 MAPK inhibition: A promising therapeutic approach for COVID-19. Extract
Meine Werkzeuge